Credit Suisse Downgrades Edwards Lifesciences (EW) to Neutral
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $90.81 --0%
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Join SI Premium – FREE
Credit Suisse downgraded Edwards Lifesciences (NYSE: EW) from Outperform to Neutral, price target raised from $81 to $90.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $81.69 yesterday.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $81.69 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Downgrades China Literature (772:HK) (CHLLF) to Neutral
- BNP Paribas Exane Downgrades Lanxess AG (LXS:GR) (LNXSF) to Underperform
- JPMorgan Downgrades Assicurazioni Generali SpA (G:IM) (ARZGY) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
